Article title: Iron deficiency in pulmonary arterial hypertension: prevalence and potential usefulness of oral supplementation
Authors: Ghio, S., Fortuni, F., Capettini, A. C., Scelsi, L., Greco, A., Vullo, E., Raineri, C., Guida, S., Turco, A., Gargiulo, C., & Oltrona Visconti, L.
Journal: Acta Cardiologica
DOI: http://dx.doi.org/10.1080/00015385.2019.1694760
The authors feel that the use of the terms “liposomal” and “liposome” throughout the proof are not appropriate. They have also found out that a phrase under “Discussion” section, has actually not conveyed the desired meaning. Hence they have proposed the following changes.
The term “liposomal” is being replaced with the term “sucrosomial” in the following places:
ABSTRACT: line 8 from the top, line 2 from the bottom
Page 1: last line
Page 2: line 23 and 25 from the top
Page 3: line 15 from the top
Page 5: line 17 from the bottom
Page 6: line 6 from the top and line 16 from the top
The term “liposome” is being replaced with the term “sucrosome” in the following places:
Page 5: line 11 from the bottom
The phrase “ferric pyrophosphate conveyed within a phospholipid membrane” is being replaced with the phrase “ferric pyrophosphate protected by a phospholipid bilayer membrane plus a sucrester matrix” on page 5, lines 15-16 from the bottom.